

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | transcytosis (GO:0045056) | 8.66947158 |
| 2 | intestinal absorption (GO:0050892) | 7.93724136 |
| 3 | cholesterol catabolic process (GO:0006707) | 7.41822682 |
| 4 | sterol catabolic process (GO:0016127) | 7.41822682 |
| 5 | cobalamin metabolic process (GO:0009235) | 7.38067165 |
| 6 | peptidyl-proline hydroxylation (GO:0019511) | 6.86970508 |
| 7 | regulation of phospholipase A2 activity (GO:0032429) | 6.54202463 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 6.52641856 |
| 9 | COPI coating of Golgi vesicle (GO:0048205) | 6.52641856 |
| 10 | negative regulation of digestive system process (GO:0060457) | 6.41798237 |
| 11 | glycolipid catabolic process (GO:0019377) | 6.16308275 |
| 12 | membrane lipid catabolic process (GO:0046466) | 6.06113335 |
| 13 | cysteine metabolic process (GO:0006534) | 5.75103408 |
| 14 | ceramide catabolic process (GO:0046514) | 5.43891293 |
| 15 | proline biosynthetic process (GO:0006561) | 5.38102134 |
| 16 | valine metabolic process (GO:0006573) | 5.36755230 |
| 17 | regulation of mononuclear cell migration (GO:0071675) | 5.31200003 |
| 18 | protein hydroxylation (GO:0018126) | 5.27154269 |
| 19 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.24446667 |
| 20 | negative regulation of interleukin-12 production (GO:0032695) | 5.23301851 |
| 21 | branched-chain amino acid catabolic process (GO:0009083) | 5.22424383 |
| 22 | positive regulation of nuclease activity (GO:0032075) | 5.00020584 |
| 23 | intestinal epithelial cell development (GO:0060576) | 4.87177380 |
| 24 | glycosphingolipid catabolic process (GO:0046479) | 4.75379341 |
| 25 | branched-chain amino acid metabolic process (GO:0009081) | 4.69207059 |
| 26 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.67931568 |
| 27 | cellular modified amino acid catabolic process (GO:0042219) | 4.67254238 |
| 28 | response to endoplasmic reticulum stress (GO:0034976) | 4.67179141 |
| 29 | protein maturation by protein folding (GO:0022417) | 4.61292860 |
| 30 | zinc ion transport (GO:0006829) | 4.61178409 |
| 31 | response to peptidoglycan (GO:0032494) | 4.54696710 |
| 32 | cellular response to unfolded protein (GO:0034620) | 4.54690503 |
| 33 | regulation of nuclease activity (GO:0032069) | 4.54464622 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 4.52693992 |
| 35 | oligosaccharide catabolic process (GO:0009313) | 4.46406224 |
| 36 | cellular response to thyroid hormone stimulus (GO:0097067) | 4.43736991 |
| 37 | mitochondrial calcium ion transport (GO:0006851) | 4.36085057 |
| 38 | amino sugar catabolic process (GO:0046348) | 4.33132567 |
| 39 | ER-nucleus signaling pathway (GO:0006984) | 4.32063670 |
| 40 | cellular response to topologically incorrect protein (GO:0035967) | 4.30350154 |
| 41 | COPII vesicle coating (GO:0048208) | 4.28857832 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.28368636 |
| 43 | signal peptide processing (GO:0006465) | 4.23214468 |
| 44 | virion attachment to host cell (GO:0019062) | 4.16517124 |
| 45 | adhesion of symbiont to host cell (GO:0044650) | 4.16517124 |
| 46 | maintenance of protein localization in organelle (GO:0072595) | 4.16179114 |
| 47 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.09463124 |
| 48 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.05431161 |
| 49 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.02851021 |
| 50 | positive regulation of heat generation (GO:0031652) | 4.01729307 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 4.00387457 |
| 52 | 4-hydroxyproline metabolic process (GO:0019471) | 3.99081685 |
| 53 | leukotriene biosynthetic process (GO:0019370) | 3.93447468 |
| 54 | endocrine pancreas development (GO:0031018) | 3.91606977 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.87833631 |
| 56 | glutamine metabolic process (GO:0006541) | 3.86554208 |
| 57 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.84583606 |
| 58 | N-acetylneuraminate metabolic process (GO:0006054) | 3.84423615 |
| 59 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.84335818 |
| 60 | T-helper 1 type immune response (GO:0042088) | 3.83699527 |
| 61 | regulation of macrophage chemotaxis (GO:0010758) | 3.83688702 |
| 62 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.83149973 |
| 63 | regulation of fever generation (GO:0031620) | 3.82497576 |
| 64 | monocyte chemotaxis (GO:0002548) | 3.82243371 |
| 65 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.80000598 |
| 66 | ER overload response (GO:0006983) | 3.79963342 |
| 67 | immunoglobulin mediated immune response (GO:0016064) | 3.78058817 |
| 68 | serine family amino acid biosynthetic process (GO:0009070) | 3.76711662 |
| 69 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.76393591 |
| 70 | GDP-mannose metabolic process (GO:0019673) | 3.75489748 |
| 71 | aspartate family amino acid catabolic process (GO:0009068) | 3.73839595 |
| 72 | adhesion of symbiont to host (GO:0044406) | 3.71900914 |
| 73 | myeloid dendritic cell differentiation (GO:0043011) | 3.69452147 |
| 74 | response to unfolded protein (GO:0006986) | 3.68149864 |
| 75 | steroid catabolic process (GO:0006706) | 3.66865587 |
| 76 | proline metabolic process (GO:0006560) | 3.63633536 |
| 77 | regulation of podosome assembly (GO:0071801) | 3.62512174 |
| 78 | antibacterial humoral response (GO:0019731) | 3.61335481 |
| 79 | NIK/NF-kappaB signaling (GO:0038061) | 3.60783579 |
| 80 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.55450904 |
| 81 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.53497379 |
| 82 | response to topologically incorrect protein (GO:0035966) | 3.53126602 |
| 83 | peptidyl-asparagine modification (GO:0018196) | 3.52847754 |
| 84 | neutrophil mediated immunity (GO:0002446) | 3.52550770 |
| 85 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.50061806 |
| 86 | barbed-end actin filament capping (GO:0051016) | 3.49809033 |
| 87 | sphingolipid catabolic process (GO:0030149) | 3.47778121 |
| 88 | response to thyroid hormone (GO:0097066) | 3.46296530 |
| 89 | creatine metabolic process (GO:0006600) | 3.45815184 |
| 90 | regulation of cholesterol storage (GO:0010885) | 3.38185795 |
| 91 | adenosine receptor signaling pathway (GO:0001973) | 3.36025936 |
| 92 | antimicrobial humoral response (GO:0019730) | 3.34111576 |
| 93 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.32071748 |
| 94 | low-density lipoprotein particle clearance (GO:0034383) | 3.31629590 |
| 95 | regulation of chemokine biosynthetic process (GO:0045073) | 3.30028980 |
| 96 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.28825383 |
| 97 | eosinophil chemotaxis (GO:0048245) | 3.27875070 |
| 98 | coenzyme catabolic process (GO:0009109) | 3.27511837 |
| 99 | positive regulation of mast cell degranulation (GO:0043306) | 3.25295932 |
| 100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.25295932 |
| 101 | protein N-linked glycosylation (GO:0006487) | 3.23529665 |
| 102 | myeloid dendritic cell activation (GO:0001773) | 3.23162865 |
| 103 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.20674333 |
| 104 | positive regulation of leukocyte degranulation (GO:0043302) | 3.20630188 |
| 105 | mitochondrion distribution (GO:0048311) | 3.20379298 |
| 106 | regulation of mast cell degranulation (GO:0043304) | 3.18152312 |
| 107 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.16992391 |
| 108 | L-phenylalanine catabolic process (GO:0006559) | 3.16992391 |
| 109 | cholesterol transport (GO:0030301) | 3.15838523 |
| 110 | sterol transport (GO:0015918) | 3.15838523 |
| 111 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.13978513 |
| 112 | granulocyte activation (GO:0036230) | 3.11830297 |
| 113 | arachidonic acid secretion (GO:0050482) | 3.10479831 |
| 114 | icosanoid secretion (GO:0032309) | 3.10479831 |
| 115 | cell redox homeostasis (GO:0045454) | 3.10081746 |
| 116 | regulation of heat generation (GO:0031650) | 3.07804388 |
| 117 | cellular response to arsenic-containing substance (GO:0071243) | 3.07551201 |
| 118 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.07474788 |
| 119 | positive regulation of antigen processing and presentation (GO:0002579) | 3.07085084 |
| 120 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.04414857 |
| 121 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.02638130 |
| 122 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.02062781 |
| 123 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.00017135 |
| 124 | dendritic cell differentiation (GO:0097028) | 2.99828599 |
| 125 | regulation of vitamin metabolic process (GO:0030656) | 2.99352741 |
| 126 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.98834864 |
| 127 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.98761062 |
| 128 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.96935161 |
| 129 | L-phenylalanine metabolic process (GO:0006558) | 2.96935161 |
| 130 | L-serine metabolic process (GO:0006563) | 2.96390827 |
| 131 | peptide catabolic process (GO:0043171) | 2.96143292 |
| 132 | macrophage activation (GO:0042116) | 2.92866224 |
| 133 | detection of molecule of bacterial origin (GO:0032490) | 2.92145003 |
| 134 | serine family amino acid metabolic process (GO:0009069) | 2.90881191 |
| 135 | positive regulation of mast cell activation (GO:0033005) | 2.90701750 |
| 136 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.90260036 |
| 137 | digestive system process (GO:0022600) | 2.89227966 |
| 138 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.88858995 |
| 139 | regulation of antigen processing and presentation (GO:0002577) | 2.88792646 |
| 140 | vesicle coating (GO:0006901) | 2.88735017 |
| 141 | eosinophil migration (GO:0072677) | 2.88389323 |
| 142 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.88188527 |
| 143 | pancreas development (GO:0031016) | 2.87315754 |
| 144 | cellular response to lipopolysaccharide (GO:0071222) | 2.87231830 |
| 145 | folic acid transport (GO:0015884) | 2.87228661 |
| 146 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.86956478 |
| 147 | germinal center formation (GO:0002467) | 2.85991481 |
| 148 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.85364766 |
| 149 | positive regulation by symbiont of host defense response (GO:0052509) | 2.84427562 |
| 150 | modulation by symbiont of host defense response (GO:0052031) | 2.84427562 |
| 151 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.84427562 |
| 152 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.84427562 |
| 153 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.84427562 |
| 154 | modulation by symbiont of host immune response (GO:0052553) | 2.84427562 |
| 155 | biotin metabolic process (GO:0006768) | 2.83079237 |
| 156 | response to acidic pH (GO:0010447) | 2.82933272 |
| 157 | regulation of chronic inflammatory response (GO:0002676) | 2.81342976 |
| 158 | regulation of interferon-alpha production (GO:0032647) | 2.81319606 |
| 159 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.80989175 |
| 160 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.80371403 |
| 161 | response to protozoan (GO:0001562) | 2.79753294 |
| 162 | macrophage differentiation (GO:0030225) | 2.79266163 |
| 163 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.78866353 |
| 164 | regulation of nitric oxide biosynthetic process (GO:0045428) | 2.77774016 |
| 165 | polarized epithelial cell differentiation (GO:0030859) | 2.77243685 |
| 166 | lung secretory cell differentiation (GO:0061140) | 2.76816126 |
| 167 | Golgi organization (GO:0007030) | 2.76753028 |
| 168 | cellular response to molecule of bacterial origin (GO:0071219) | 2.76625362 |
| 169 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.76562814 |
| 170 | regulation of leukocyte degranulation (GO:0043300) | 2.75431417 |
| 171 | regulation of digestive system process (GO:0044058) | 2.73156104 |
| 172 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.72982741 |
| 173 | regulation of monocyte chemotaxis (GO:0090025) | 2.72682618 |
| 174 | negative regulation of cell fate commitment (GO:0010454) | 2.72078511 |
| 175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175) | 2.71921286 |
| 176 | myeloid cell activation involved in immune response (GO:0002275) | 2.71663765 |
| 177 | histamine secretion (GO:0001821) | 2.71150359 |
| 178 | keratan sulfate catabolic process (GO:0042340) | 2.70620727 |
| 179 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.69242199 |
| 180 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.68699103 |
| 181 | myeloid leukocyte mediated immunity (GO:0002444) | 2.67255409 |
| 182 | negative regulation of granulocyte differentiation (GO:0030853) | 2.66989590 |
| 183 | mature B cell differentiation involved in immune response (GO:0002313) | 2.65427469 |
| 184 | positive regulation of cholesterol efflux (GO:0010875) | 2.64892499 |
| 185 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.64827542 |
| 186 | innate immune response in mucosa (GO:0002227) | 2.62470796 |
| 187 | sulfur amino acid catabolic process (GO:0000098) | 2.62364465 |
| 188 | regulation of oxidative stress-induced cell death (GO:1903201) | 2.59165759 |
| 189 | intestinal cholesterol absorption (GO:0030299) | 17.7409762 |
| 190 | exocrine pancreas development (GO:0031017) | 15.9162104 |
| 191 | digestion (GO:0007586) | 13.2726293 |
| 192 | protein retention in ER lumen (GO:0006621) | 12.2196259 |
| 193 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 11.5693614 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 7.90482703 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.93807489 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.92407342 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.40547049 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 4.36974483 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.89771664 |
| 7 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.75863410 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.63663543 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.49295637 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.14289861 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.09613470 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.91307509 |
| 13 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.87924581 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.81406955 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.81309937 |
| 16 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.79264413 |
| 17 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.65954631 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.60608690 |
| 19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.60450471 |
| 20 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 2.55407292 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.54675233 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.41826135 |
| 23 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.38679827 |
| 24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.37100656 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.30920032 |
| 26 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.27468715 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.24911258 |
| 28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.24143967 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.24025759 |
| 30 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.21561914 |
| 31 | SPI1_23127762_ChIP-Seq_K562_Human | 2.12849737 |
| 32 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.12764877 |
| 33 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.12764877 |
| 34 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.12764877 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.11446509 |
| 36 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.08873313 |
| 37 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08550233 |
| 38 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.04923746 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.04858015 |
| 40 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.99426829 |
| 41 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.97869289 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.90062067 |
| 43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.83895335 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.82920688 |
| 45 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.81199985 |
| 46 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.79282492 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78672405 |
| 48 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.77231885 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.76381181 |
| 50 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74990887 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73047472 |
| 52 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.72621084 |
| 53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.72129722 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.68998082 |
| 55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64132217 |
| 56 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62454966 |
| 57 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.60329194 |
| 58 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58704610 |
| 59 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.56970292 |
| 60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.55433062 |
| 61 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.54961924 |
| 62 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49839321 |
| 63 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.47452996 |
| 64 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.47190132 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46272539 |
| 66 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.44920596 |
| 67 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.43504966 |
| 68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42143897 |
| 69 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39140241 |
| 70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.38458215 |
| 71 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.38353279 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37967645 |
| 73 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.37874333 |
| 74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.37784228 |
| 75 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.36770101 |
| 76 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36621435 |
| 77 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.35850127 |
| 78 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.33715154 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.30396512 |
| 80 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29911030 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.29502110 |
| 82 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.28566187 |
| 83 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.27546093 |
| 84 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.27222204 |
| 85 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26129905 |
| 86 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.25208819 |
| 87 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.24908594 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24788181 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24554782 |
| 90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24030976 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22773313 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22329545 |
| 93 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21640445 |
| 94 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.19573530 |
| 95 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19487680 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19405583 |
| 97 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.19341333 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.18804685 |
| 99 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.17214603 |
| 100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17026864 |
| 101 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 1.15616673 |
| 102 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15313949 |
| 103 | MAF_26560356_Chip-Seq_TH1_Human | 1.13523320 |
| 104 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.12004633 |
| 105 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11600644 |
| 106 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.11076840 |
| 107 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.10372351 |
| 108 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.10072924 |
| 109 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09767590 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09302546 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09248582 |
| 112 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.08748893 |
| 113 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08661667 |
| 114 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.08328670 |
| 115 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08184987 |
| 116 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.08103221 |
| 117 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07703562 |
| 118 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07359472 |
| 119 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06883944 |
| 120 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.06757154 |
| 121 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.06505407 |
| 122 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06056450 |
| 123 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.05740201 |
| 124 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05684211 |
| 125 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.03824836 |
| 126 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.03616737 |
| 127 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02929236 |
| 128 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.02772379 |
| 129 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02644733 |
| 130 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.02158117 |
| 131 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.00549232 |
| 132 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00414484 |
| 133 | P68_20966046_ChIP-Seq_HELA_Human | 1.00105456 |
| 134 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96688799 |
| 135 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95547175 |
| 136 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95547175 |
| 137 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95083398 |
| 138 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94163986 |
| 139 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.94085415 |
| 140 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93883777 |
| 141 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.93380706 |
| 142 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.93026542 |
| 143 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92761875 |
| 144 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92704213 |
| 145 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91715163 |
| 146 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.90978610 |
| 147 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90908150 |
| 148 | MAF_26560356_Chip-Seq_TH2_Human | 0.90787762 |
| 149 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90771590 |
| 150 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.90651232 |
| 151 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90402368 |
| 152 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.89997933 |
| 153 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89883419 |
| 154 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.89205676 |
| 155 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88524001 |
| 156 | UTX_26944678_Chip-Seq_JUKART_Human | 0.87737908 |
| 157 | ERA_21632823_ChIP-Seq_H3396_Human | 0.86450018 |
| 158 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.85557649 |
| 159 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.85224793 |
| 160 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.84965229 |
| 161 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.84464855 |
| 162 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.84098761 |
| 163 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.83250717 |
| 164 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.83001995 |
| 165 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.82938306 |
| 166 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.82588140 |
| 167 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.82520167 |
| 168 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82002018 |
| 169 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.80757115 |
| 170 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.80681219 |
| 171 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79709656 |
| 172 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79359920 |
| 173 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.77646762 |
| 174 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77571449 |
| 175 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.74941309 |
| 176 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.74677115 |
| 177 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.74390744 |
| 178 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.71046766 |
| 179 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.70573059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005083_abnormal_biliary_tract | 8.99999101 |
| 2 | MP0001666_abnormal_nutrient_absorption | 8.91916847 |
| 3 | MP0005220_abnormal_exocrine_pancreas | 6.56314122 |
| 4 | MP0005365_abnormal_bile_salt | 6.30972249 |
| 5 | MP0005084_abnormal_gallbladder_morpholo | 4.88633535 |
| 6 | MP0003868_abnormal_feces_composition | 4.84054037 |
| 7 | MP0003303_peritoneal_inflammation | 4.50782852 |
| 8 | MP0006082_CNS_inflammation | 3.79125987 |
| 9 | MP0009840_abnormal_foam_cell | 3.57409478 |
| 10 | MP0002148_abnormal_hypersensitivity_rea | 3.24305196 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 3.16688311 |
| 12 | MP0003436_decreased_susceptibility_to | 2.99794627 |
| 13 | MP0004510_myositis | 2.99724001 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.86436506 |
| 15 | MP0002693_abnormal_pancreas_physiology | 2.80337174 |
| 16 | MP0003172_abnormal_lysosome_physiology | 2.76882706 |
| 17 | MP0003724_increased_susceptibility_to | 2.75487001 |
| 18 | MP0000343_altered_response_to | 2.64376566 |
| 19 | MP0009785_altered_susceptibility_to | 2.64132549 |
| 20 | MP0003075_altered_response_to | 2.54042943 |
| 21 | MP0003959_abnormal_lean_body | 2.50300605 |
| 22 | MP0002419_abnormal_innate_immunity | 2.47660279 |
| 23 | MP0000604_amyloidosis | 2.41924141 |
| 24 | MP0001664_abnormal_digestion | 2.41226081 |
| 25 | MP0005000_abnormal_immune_tolerance | 2.27301359 |
| 26 | MP0002139_abnormal_hepatobiliary_system | 2.25735360 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 2.22574810 |
| 28 | MP0001790_abnormal_immune_system | 2.22258605 |
| 29 | MP0005387_immune_system_phenotype | 2.22258605 |
| 30 | MP0005671_abnormal_response_to | 2.21689930 |
| 31 | MP0005025_abnormal_response_to | 2.17137574 |
| 32 | MP0009764_decreased_sensitivity_to | 2.14610670 |
| 33 | MP0001835_abnormal_antigen_presentation | 2.13993145 |
| 34 | MP0001944_abnormal_pancreas_morphology | 2.04206843 |
| 35 | MP0010234_abnormal_vibrissa_follicle | 2.03355514 |
| 36 | MP0002254_reproductive_system_inflammat | 2.00233859 |
| 37 | MP0001533_abnormal_skeleton_physiology | 1.99844834 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 1.98691131 |
| 39 | MP0004264_abnormal_extraembryonic_tissu | 1.97695733 |
| 40 | MP0001853_heart_inflammation | 1.90152611 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.89587315 |
| 42 | MP0003690_abnormal_glial_cell | 1.87944305 |
| 43 | MP0009278_abnormal_bone_marrow | 1.83804260 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.82197434 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.77446202 |
| 46 | MP0002723_abnormal_immune_serum | 1.76168510 |
| 47 | MP0003252_abnormal_bile_duct | 1.71532029 |
| 48 | MP0000685_abnormal_immune_system | 1.65250493 |
| 49 | MP0003453_abnormal_keratinocyte_physiol | 1.61925690 |
| 50 | MP0002928_abnormal_bile_duct | 1.55636278 |
| 51 | MP0003448_altered_tumor_morphology | 1.55496249 |
| 52 | MP0005448_abnormal_energy_balance | 1.54759546 |
| 53 | MP0008469_abnormal_protein_level | 1.53661591 |
| 54 | MP0001800_abnormal_humoral_immune | 1.53006084 |
| 55 | MP0005397_hematopoietic_system_phenotyp | 1.52973053 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.52973053 |
| 57 | MP0005310_abnormal_salivary_gland | 1.49829015 |
| 58 | MP0002405_respiratory_system_inflammati | 1.48779078 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.47402102 |
| 60 | MP0001819_abnormal_immune_cell | 1.42799118 |
| 61 | MP0002420_abnormal_adaptive_immunity | 1.42600986 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.42496879 |
| 63 | MP0004233_abnormal_muscle_weight | 1.40384417 |
| 64 | MP0003638_abnormal_response/metabolism_ | 1.39346765 |
| 65 | MP0000858_altered_metastatic_potential | 1.38844637 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.37412921 |
| 67 | MP0004947_skin_inflammation | 1.36259527 |
| 68 | MP0005166_decreased_susceptibility_to | 1.34470301 |
| 69 | MP0008004_abnormal_stomach_pH | 1.33004298 |
| 70 | MP0000920_abnormal_myelination | 1.32209690 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 1.24718668 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.24232867 |
| 73 | MP0005165_increased_susceptibility_to | 1.22242702 |
| 74 | MP0001542_abnormal_bone_strength | 1.18454561 |
| 75 | MP0005332_abnormal_amino_acid | 1.16332096 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 1.15943706 |
| 77 | MP0008438_abnormal_cutaneous_collagen | 1.10152046 |
| 78 | MP0003828_pulmonary_edema | 1.08294841 |
| 79 | MP0009333_abnormal_splenocyte_physiolog | 1.06742483 |
| 80 | MP0002078_abnormal_glucose_homeostasis | 1.03566185 |
| 81 | MP0000613_abnormal_salivary_gland | 1.01519463 |
| 82 | MP0003045_fibrosis | 1.00881112 |
| 83 | MP0000470_abnormal_stomach_morphology | 0.98891340 |
| 84 | MP0001873_stomach_inflammation | 0.98483663 |
| 85 | MP0000003_abnormal_adipose_tissue | 0.97883841 |
| 86 | MP0008260_abnormal_autophagy | 0.97638624 |
| 87 | MP0003634_abnormal_glial_cell | 0.95139764 |
| 88 | MP0009780_abnormal_chondrocyte_physiolo | 0.94870697 |
| 89 | MP0005408_hypopigmentation | 0.94717207 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.94437673 |
| 91 | MP0009384_cardiac_valve_regurgitation | 0.94353858 |
| 92 | MP0000716_abnormal_immune_system | 0.93798309 |
| 93 | MP0009643_abnormal_urine_homeostasis | 0.92921277 |
| 94 | MP0005451_abnormal_body_composition | 0.89933027 |
| 95 | MP0005390_skeleton_phenotype | 0.88968261 |
| 96 | MP0005164_abnormal_response_to | 0.88528120 |
| 97 | MP0005595_abnormal_vascular_smooth | 0.87315707 |
| 98 | MP0003279_aneurysm | 0.86345790 |
| 99 | MP0010307_abnormal_tumor_latency | 0.86017040 |
| 100 | MP0006054_spinal_hemorrhage | 0.82253208 |
| 101 | MP0002090_abnormal_vision | 0.80206618 |
| 102 | MP0002933_joint_inflammation | 0.79390868 |
| 103 | MP0009763_increased_sensitivity_to | 0.78640813 |
| 104 | MP0010386_abnormal_urinary_bladder | 0.76392952 |
| 105 | MP0005647_abnormal_sex_gland | 0.74799805 |
| 106 | MP0005023_abnormal_wound_healing | 0.74790746 |
| 107 | MP0003953_abnormal_hormone_level | 0.73973725 |
| 108 | MP0003195_calcinosis | 0.73402515 |
| 109 | MP0005535_abnormal_body_temperature | 0.72896568 |
| 110 | MP0000490_abnormal_crypts_of | 0.70291098 |
| 111 | MP0008961_abnormal_basal_metabolism | 0.70023248 |
| 112 | MP0003633_abnormal_nervous_system | 0.69544341 |
| 113 | MP0002429_abnormal_blood_cell | 0.68834008 |
| 114 | MP0004883_abnormal_blood_vessel | 0.68100176 |
| 115 | MP0000689_abnormal_spleen_morphology | 0.67095607 |
| 116 | MP0005058_abnormal_lysosome_morphology | 0.66362340 |
| 117 | MP0008874_decreased_physiological_sensi | 0.66113952 |
| 118 | MP0003091_abnormal_cell_migration | 0.66007827 |
| 119 | MP0003283_abnormal_digestive_organ | 0.64804592 |
| 120 | MP0002098_abnormal_vibrissa_morphology | 0.64654113 |
| 121 | MP0000249_abnormal_blood_vessel | 0.64005672 |
| 122 | MP0003183_abnormal_peptide_metabolism | 0.61809297 |
| 123 | MP0008789_abnormal_olfactory_epithelium | 0.61787911 |
| 124 | MP0003879_abnormal_hair_cell | 0.61323852 |
| 125 | MP0001663_abnormal_digestive_system | 0.61231687 |
| 126 | MP0002398_abnormal_bone_marrow | 0.60542745 |
| 127 | MP0001851_eye_inflammation | 0.59700296 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58636734 |
| 129 | MP0000465_gastrointestinal_hemorrhage | 0.57886330 |
| 130 | MP0001849_ear_inflammation | 0.57216268 |
| 131 | MP0004272_abnormal_basement_membrane | 0.57115897 |
| 132 | MP0004043_abnormal_pH_regulation | 0.55682258 |
| 133 | MP0002796_impaired_skin_barrier | 0.55145640 |
| 134 | MP0005452_abnormal_adipose_tissue | 0.54864490 |
| 135 | MP0009765_abnormal_xenobiotic_induced | 0.54309041 |
| 136 | MP0002060_abnormal_skin_morphology | 0.53771146 |
| 137 | MP0000598_abnormal_liver_morphology | 0.52390694 |
| 138 | MP0002089_abnormal_postnatal_growth/wei | 0.51330471 |
| 139 | MP0010329_abnormal_lipoprotein_level | 0.51125547 |
| 140 | MP0005381_digestive/alimentary_phenotyp | 0.50686711 |
| 141 | MP0003186_abnormal_redox_activity | 0.46446649 |
| 142 | MP0005187_abnormal_penis_morphology | 0.46326595 |
| 143 | MP0005375_adipose_tissue_phenotype | 0.46266055 |
| 144 | MP0000609_abnormal_liver_physiology | 0.46159973 |
| 145 | MP0000371_diluted_coat_color | 0.45651695 |
| 146 | MP0001731_abnormal_postnatal_growth | 0.44991157 |
| 147 | MP0001756_abnormal_urination | 0.44790785 |
| 148 | MP0001764_abnormal_homeostasis | 0.44772649 |
| 149 | MP0010678_abnormal_skin_adnexa | 0.44593508 |
| 150 | MP0002896_abnormal_bone_mineralization | 0.42244297 |
| 151 | MP0003806_abnormal_nucleotide_metabolis | 0.41689677 |
| 152 | MP0002009_preneoplasia | 0.41495629 |
| 153 | MP0001845_abnormal_inflammatory_respons | 0.41253187 |
| 154 | MP0005499_abnormal_olfactory_system | 0.40534395 |
| 155 | MP0005394_taste/olfaction_phenotype | 0.40534395 |
| 156 | MP0002876_abnormal_thyroid_physiology | 0.40259532 |
| 157 | MP0004185_abnormal_adipocyte_glucose | 0.39939970 |
| 158 | MP0000750_abnormal_muscle_regeneration | 0.39390915 |
| 159 | MP0000377_abnormal_hair_follicle | 0.38969817 |
| 160 | MP0001765_abnormal_ion_homeostasis | 0.38493779 |
| 161 | MP0005319_abnormal_enzyme/_coenzyme | 0.38416340 |
| 162 | MP0003795_abnormal_bone_structure | 0.35806666 |
| 163 | MP0006036_abnormal_mitochondrial_physio | 0.35118917 |
| 164 | MP0005636_abnormal_mineral_homeostasis | 0.34228017 |
| 165 | MP0003943_abnormal_hepatobiliary_system | 0.33707389 |
| 166 | MP0000367_abnormal_coat/_hair | 0.33225589 |
| 167 | MP0000566_synostosis | 0.32184151 |
| 168 | MP0005334_abnormal_fat_pad | 0.32106276 |
| 169 | MP0003656_abnormal_erythrocyte_physiolo | 0.31094744 |
| 170 | MP0005360_urolithiasis | 0.30464739 |
| 171 | MP0000647_abnormal_sebaceous_gland | 0.30322857 |
| 172 | MP0009642_abnormal_blood_homeostasis | 0.27669280 |
| 173 | MP0005275_abnormal_skin_tensile | 0.27313323 |
| 174 | MP0002168_other_aberrant_phenotype | 0.25999162 |
| 175 | MP0002877_abnormal_melanocyte_morpholog | 0.25649979 |
| 176 | MP0000537_abnormal_urethra_morphology | 0.24624734 |
| 177 | MP0002069_abnormal_eating/drinking_beha | 0.23092573 |
| 178 | MP0002295_abnormal_pulmonary_circulatio | 0.23048527 |
| 179 | MP0003329_amyloid_beta_deposits | 0.21145561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steatorrhea (HP:0002570) | 8.34639697 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 8.25594203 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 8.25594203 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 8.25594203 |
| 5 | Fat malabsorption (HP:0002630) | 6.98887017 |
| 6 | Gout (HP:0001997) | 6.46488819 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 6.41531543 |
| 8 | Disinhibition (HP:0000734) | 5.95851807 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 5.66201033 |
| 10 | Exocrine pancreatic insufficiency (HP:0001738) | 5.63101444 |
| 11 | Short chin (HP:0000331) | 5.27086221 |
| 12 | Decreased subcutaneous fat (HP:0001002) | 5.26783521 |
| 13 | Mutism (HP:0002300) | 5.07433588 |
| 14 | Loss of speech (HP:0002371) | 4.93267539 |
| 15 | Abnormality of subcutaneous fat tissue (HP:0001001) | 4.82227502 |
| 16 | Type I diabetes mellitus (HP:0100651) | 4.79531368 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.68807246 |
| 18 | Nuclear cataract (HP:0100018) | 4.65664236 |
| 19 | Abnormal pancreas size (HP:0012094) | 4.55205589 |
| 20 | Abnormality of the intrinsic pathway (HP:0010989) | 4.54872271 |
| 21 | Axonal loss (HP:0003447) | 4.54013196 |
| 22 | Glomerulonephritis (HP:0000099) | 4.36694542 |
| 23 | Abnormality of macrophages (HP:0004311) | 4.28486668 |
| 24 | Neurofibrillary tangles (HP:0002185) | 4.14247404 |
| 25 | Maternal diabetes (HP:0009800) | 4.10199265 |
| 26 | Hypoplasia of the pons (HP:0012110) | 4.08137400 |
| 27 | Tubulointerstitial fibrosis (HP:0005576) | 4.03764637 |
| 28 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.00347640 |
| 29 | Complement deficiency (HP:0004431) | 3.82106919 |
| 30 | Abnormality of the pons (HP:0007361) | 3.78761624 |
| 31 | Agnosia (HP:0010524) | 3.72889731 |
| 32 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.67354426 |
| 33 | Pancreatitis (HP:0001733) | 3.61442857 |
| 34 | Premature skin wrinkling (HP:0100678) | 3.61070954 |
| 35 | Ketoacidosis (HP:0001993) | 3.60426133 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.56143436 |
| 37 | Inappropriate behavior (HP:0000719) | 3.49139432 |
| 38 | Recurrent bacterial skin infections (HP:0005406) | 3.48912124 |
| 39 | Ketosis (HP:0001946) | 3.46978560 |
| 40 | Tubulointerstitial nephritis (HP:0001970) | 3.44844568 |
| 41 | Autoimmune thrombocytopenia (HP:0001973) | 3.43695854 |
| 42 | Joint stiffness (HP:0001387) | 3.40519455 |
| 43 | Upper motor neuron abnormality (HP:0002127) | 3.37066791 |
| 44 | Cortical dysplasia (HP:0002539) | 3.33601991 |
| 45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.33359518 |
| 46 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.31233671 |
| 47 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.31233671 |
| 48 | Apathy (HP:0000741) | 3.24405447 |
| 49 | Hypoproteinemia (HP:0003075) | 3.23537681 |
| 50 | Hypoglycemic coma (HP:0001325) | 3.21503609 |
| 51 | Diminished motivation (HP:0000745) | 3.13523251 |
| 52 | Eczematoid dermatitis (HP:0000976) | 3.10171028 |
| 53 | Hypoglycemic seizures (HP:0002173) | 3.10111646 |
| 54 | Abnormality of complement system (HP:0005339) | 2.99856145 |
| 55 | Spontaneous hematomas (HP:0007420) | 2.97770758 |
| 56 | Potter facies (HP:0002009) | 2.94975751 |
| 57 | Facial shape deformation (HP:0011334) | 2.94975751 |
| 58 | Neuronal loss in central nervous system (HP:0002529) | 2.92068554 |
| 59 | Cerebral inclusion bodies (HP:0100314) | 2.92047264 |
| 60 | Personality changes (HP:0000751) | 2.89465886 |
| 61 | Hematochezia (HP:0002573) | 2.87427685 |
| 62 | Increased purine levels (HP:0004368) | 2.85498769 |
| 63 | Hyperuricemia (HP:0002149) | 2.85498769 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.83663540 |
| 65 | Purpura (HP:0000979) | 2.83518930 |
| 66 | Carpal bone hypoplasia (HP:0001498) | 2.83083580 |
| 67 | Esophageal varix (HP:0002040) | 2.83003932 |
| 68 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.80551003 |
| 69 | Mediastinal lymphadenopathy (HP:0100721) | 2.78679363 |
| 70 | Abnormality of the common coagulation pathway (HP:0010990) | 2.78656823 |
| 71 | Hypoplasia of the uterus (HP:0000013) | 2.77012498 |
| 72 | Stomatitis (HP:0010280) | 2.75914951 |
| 73 | Amyloidosis (HP:0011034) | 2.75119484 |
| 74 | Long foot (HP:0001833) | 2.74980088 |
| 75 | Late onset (HP:0003584) | 2.70475109 |
| 76 | Orchitis (HP:0100796) | 2.67054530 |
| 77 | Progressive neurologic deterioration (HP:0002344) | 2.66859127 |
| 78 | Vacuolated lymphocytes (HP:0001922) | 2.65085214 |
| 79 | Hyperglycinemia (HP:0002154) | 2.63544164 |
| 80 | Dysostosis multiplex (HP:0000943) | 2.61741249 |
| 81 | Increased serum ferritin (HP:0003281) | 2.61723081 |
| 82 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.61352166 |
| 83 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.61238290 |
| 84 | Abnormal tarsal ossification (HP:0008369) | 2.57666864 |
| 85 | Myositis (HP:0100614) | 2.54413278 |
| 86 | Dementia (HP:0000726) | 2.53720541 |
| 87 | Retinal atrophy (HP:0001105) | 2.53500333 |
| 88 | Abnormality of the renal cortex (HP:0011035) | 2.53446266 |
| 89 | Prolonged neonatal jaundice (HP:0006579) | 2.50098352 |
| 90 | Ventricular fibrillation (HP:0001663) | 2.45827515 |
| 91 | Hyperglycinuria (HP:0003108) | 2.44104701 |
| 92 | Abnormal protein glycosylation (HP:0012346) | 2.43942785 |
| 93 | Abnormal glycosylation (HP:0012345) | 2.43942785 |
| 94 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.43942785 |
| 95 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.43942785 |
| 96 | Optic neuritis (HP:0100653) | 2.43662950 |
| 97 | Retrobulbar optic neuritis (HP:0100654) | 2.43662950 |
| 98 | Pectus carinatum (HP:0000768) | 2.42744689 |
| 99 | Pathologic fracture (HP:0002756) | 2.41289251 |
| 100 | Basal ganglia calcification (HP:0002135) | 2.40831100 |
| 101 | Metaphyseal irregularity (HP:0003025) | 2.40090237 |
| 102 | Conjugated hyperbilirubinemia (HP:0002908) | 2.39279373 |
| 103 | Tubulointerstitial abnormality (HP:0001969) | 2.36457715 |
| 104 | Congenital glaucoma (HP:0001087) | 2.36082850 |
| 105 | Right ventricular cardiomyopathy (HP:0011663) | 2.34587517 |
| 106 | Hypoplasia of the odontoid process (HP:0003311) | 2.31952790 |
| 107 | Fatigue (HP:0012378) | 2.31666036 |
| 108 | Conjunctival telangiectasia (HP:0000524) | 2.31260382 |
| 109 | Hepatosplenomegaly (HP:0001433) | 2.28082492 |
| 110 | Prenatal maternal abnormality (HP:0002686) | 2.25580191 |
| 111 | Supranuclear gaze palsy (HP:0000605) | 2.25228125 |
| 112 | Renal salt wasting (HP:0000127) | 2.24380364 |
| 113 | Optic nerve hypoplasia (HP:0000609) | 2.23897927 |
| 114 | Petechiae (HP:0000967) | 2.23258094 |
| 115 | Barrel-shaped chest (HP:0001552) | 2.23020600 |
| 116 | Nephritis (HP:0000123) | 2.22722653 |
| 117 | Abnormality of glycine metabolism (HP:0010895) | 2.20678987 |
| 118 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.20678987 |
| 119 | Asymmetric septal hypertrophy (HP:0001670) | 2.20514320 |
| 120 | Symptomatic seizures (HP:0011145) | 2.19423689 |
| 121 | Progressive muscle weakness (HP:0003323) | 2.17919685 |
| 122 | Hyperglycemia (HP:0003074) | 2.16297627 |
| 123 | Rectal prolapse (HP:0002035) | 2.15618571 |
| 124 | Peripheral demyelination (HP:0011096) | 2.15252163 |
| 125 | Obstructive lung disease (HP:0006536) | 2.14120086 |
| 126 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14120086 |
| 127 | Vertebral compression fractures (HP:0002953) | 2.12701331 |
| 128 | Mucopolysacchariduria (HP:0008155) | 2.08517793 |
| 129 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.08517793 |
| 130 | Interstitial pulmonary disease (HP:0006530) | 2.07351076 |
| 131 | Abnormality of purine metabolism (HP:0004352) | 2.05945509 |
| 132 | Abnormality of iron homeostasis (HP:0011031) | 2.05446081 |
| 133 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.03875438 |
| 134 | Polyneuropathy (HP:0001271) | 2.03739548 |
| 135 | Acute hepatic failure (HP:0006554) | 2.03612554 |
| 136 | Small epiphyses (HP:0010585) | 2.03422823 |
| 137 | Memory impairment (HP:0002354) | 2.02683972 |
| 138 | Neonatal death (HP:0003811) | 2.02632873 |
| 139 | Thoracic kyphosis (HP:0002942) | 1.99105083 |
| 140 | Ankyloglossia (HP:0010296) | 1.98705530 |
| 141 | Zonular cataract (HP:0010920) | 1.98389409 |
| 142 | Large for gestational age (HP:0001520) | 1.98369354 |
| 143 | Abnormal foot bone ossification (HP:0010675) | 1.97891298 |
| 144 | Beaking of vertebral bodies (HP:0004568) | 1.97709920 |
| 145 | Coxa valga (HP:0002673) | 1.97207030 |
| 146 | Type II lissencephaly (HP:0007260) | 1.96122122 |
| 147 | Tubular atrophy (HP:0000092) | 1.95634134 |
| 148 | Bone pain (HP:0002653) | 1.93817865 |
| 149 | Abnormality of the nasal mucosa (HP:0000433) | 1.93667487 |
| 150 | Pulmonary infiltrates (HP:0002113) | 1.93483187 |
| 151 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.92906813 |
| 152 | Prolonged QT interval (HP:0001657) | 1.92741567 |
| 153 | Gingivitis (HP:0000230) | 1.91951157 |
| 154 | Cardiomegaly (HP:0001640) | 1.91894363 |
| 155 | Severe short stature (HP:0003510) | 1.88858196 |
| 156 | Cortical visual impairment (HP:0100704) | 1.87376052 |
| 157 | Malnutrition (HP:0004395) | 1.85656640 |
| 158 | Myocardial infarction (HP:0001658) | 1.85404404 |
| 159 | Congenital sensorineural hearing impairment (HP:0008527) | 1.83913657 |
| 160 | Abnormality of the basal ganglia (HP:0002134) | 1.83194564 |
| 161 | Abnormality of the odontoid process (HP:0003310) | 1.82416120 |
| 162 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.82103270 |
| 163 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.82103270 |
| 164 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.82103270 |
| 165 | Reduced antithrombin III activity (HP:0001976) | 1.79975775 |
| 166 | Increased CSF protein (HP:0002922) | 1.79242442 |
| 167 | Homocystinuria (HP:0002156) | 1.78969248 |
| 168 | Abnormality of homocysteine metabolism (HP:0010919) | 1.78969248 |
| 169 | Unilateral renal agenesis (HP:0000122) | 1.78676265 |
| 170 | Nausea (HP:0002018) | 1.78352365 |
| 171 | Epiphyseal dysplasia (HP:0002656) | 1.77187379 |
| 172 | Urinary incontinence (HP:0000020) | 1.76619331 |
| 173 | Global brain atrophy (HP:0002283) | 1.76600445 |
| 174 | Progressive visual loss (HP:0000529) | 1.75928687 |
| 175 | Glomerulosclerosis (HP:0000096) | 1.74837353 |
| 176 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.73311172 |
| 177 | Bone cyst (HP:0012062) | 1.73068116 |
| 178 | Abnormality of methionine metabolism (HP:0010901) | 1.73053459 |
| 179 | Multiple enchondromatosis (HP:0005701) | 1.73029453 |
| 180 | Recurrent skin infections (HP:0001581) | 1.72882182 |
| 181 | Limb hypertonia (HP:0002509) | 1.72619124 |
| 182 | Mesangial abnormality (HP:0001966) | 1.70999560 |
| 183 | Abnormality of the periventricular white matter (HP:0002518) | 1.70917491 |
| 184 | Acrocyanosis (HP:0001063) | 1.70881732 |
| 185 | Tetraparesis (HP:0002273) | 1.69891863 |
| 186 | Hemoptysis (HP:0002105) | 1.69334437 |
| 187 | J-shaped sella turcica (HP:0002680) | 1.68566418 |
| 188 | Abnormality of lateral ventricle (HP:0030047) | 1.67252879 |
| 189 | Keratoconjunctivitis sicca (HP:0001097) | 1.63805242 |
| 190 | Mucosal telangiectasiae (HP:0100579) | 1.62303033 |
| 191 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.62200447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 8.78576668 |
| 2 | ERN1 | 5.63424730 |
| 3 | EIF2AK3 | 4.13781783 |
| 4 | MAP2K2 | 3.70342719 |
| 5 | FRK | 3.45082570 |
| 6 | INSRR | 3.40563332 |
| 7 | GRK7 | 3.03250913 |
| 8 | MAP3K11 | 2.85626419 |
| 9 | TRIB3 | 2.85241851 |
| 10 | TAOK2 | 2.80623775 |
| 11 | BLK | 2.78128866 |
| 12 | MAP3K14 | 2.71015228 |
| 13 | TAOK3 | 2.51075259 |
| 14 | TBK1 | 2.49640633 |
| 15 | PKN2 | 2.37248964 |
| 16 | TAOK1 | 2.23435052 |
| 17 | MATK | 2.18129318 |
| 18 | ACVR1B | 2.11765122 |
| 19 | MAPKAPK3 | 2.10629495 |
| 20 | PIM2 | 2.08939420 |
| 21 | FGR | 2.02215239 |
| 22 | MAPK15 | 1.89055889 |
| 23 | IKBKB | 1.84517200 |
| 24 | RIPK4 | 1.83931964 |
| 25 | ABL2 | 1.83283073 |
| 26 | ZAP70 | 1.79900090 |
| 27 | IRAK3 | 1.76087086 |
| 28 | CSK | 1.71981815 |
| 29 | SCYL2 | 1.70613960 |
| 30 | MAP2K3 | 1.64691914 |
| 31 | TYK2 | 1.64429124 |
| 32 | LATS1 | 1.56763660 |
| 33 | MOS | 1.53060708 |
| 34 | TESK1 | 1.49519252 |
| 35 | MAP2K1 | 1.47235421 |
| 36 | MAP4K1 | 1.45857013 |
| 37 | WNK4 | 1.42054753 |
| 38 | PRPF4B | 1.40307149 |
| 39 | PAK2 | 1.35045734 |
| 40 | MAP3K2 | 1.33467049 |
| 41 | PTK6 | 1.31991896 |
| 42 | CSF1R | 1.25116993 |
| 43 | LMTK2 | 1.25055683 |
| 44 | TGFBR1 | 1.23928346 |
| 45 | IKBKE | 1.22298804 |
| 46 | PIK3CG | 1.21568466 |
| 47 | SIK1 | 1.20206824 |
| 48 | NME1 | 1.18356794 |
| 49 | ADRBK2 | 1.17962397 |
| 50 | PDGFRB | 1.12651217 |
| 51 | RPS6KB2 | 1.11864851 |
| 52 | TESK2 | 1.08814641 |
| 53 | EPHB2 | 1.08047132 |
| 54 | DYRK1A | 1.06719535 |
| 55 | EEF2K | 1.06287303 |
| 56 | PIK3CA | 1.05792729 |
| 57 | CHUK | 1.00629024 |
| 58 | JAK3 | 0.99226057 |
| 59 | STK39 | 0.98961476 |
| 60 | FLT3 | 0.94783455 |
| 61 | FES | 0.94087477 |
| 62 | MAP3K13 | 0.92086034 |
| 63 | LYN | 0.92079423 |
| 64 | NME2 | 0.91894455 |
| 65 | TYRO3 | 0.85217070 |
| 66 | SYK | 0.84806819 |
| 67 | SIK3 | 0.84578927 |
| 68 | TXK | 0.84475543 |
| 69 | MAP3K5 | 0.82869347 |
| 70 | PDK2 | 0.79819318 |
| 71 | IRAK2 | 0.78054451 |
| 72 | CAMKK1 | 0.75958281 |
| 73 | MARK3 | 0.72597970 |
| 74 | DYRK1B | 0.72427534 |
| 75 | MTOR | 0.70713539 |
| 76 | ARAF | 0.69533994 |
| 77 | FER | 0.68999899 |
| 78 | PAK4 | 0.66895839 |
| 79 | BMPR2 | 0.64489060 |
| 80 | CDK6 | 0.62262523 |
| 81 | DAPK2 | 0.61962914 |
| 82 | MAP2K6 | 0.61822464 |
| 83 | RET | 0.61232793 |
| 84 | CAMKK2 | 0.61192788 |
| 85 | LRRK2 | 0.60521185 |
| 86 | PRKCI | 0.59526651 |
| 87 | LCK | 0.58603862 |
| 88 | PRKCH | 0.57311167 |
| 89 | ICK | 0.56748392 |
| 90 | DAPK3 | 0.55273454 |
| 91 | MAP3K1 | 0.54131486 |
| 92 | RIPK1 | 0.54042954 |
| 93 | PDPK1 | 0.50796406 |
| 94 | MAPK4 | 0.50763317 |
| 95 | PDGFRA | 0.50128094 |
| 96 | LIMK1 | 0.50003762 |
| 97 | RPS6KB1 | 0.49270894 |
| 98 | MET | 0.49239166 |
| 99 | TNK2 | 0.47874089 |
| 100 | HIPK2 | 0.47489932 |
| 101 | PRKD3 | 0.47170870 |
| 102 | IRAK4 | 0.46640870 |
| 103 | PTK2 | 0.46002182 |
| 104 | DDR2 | 0.45901821 |
| 105 | PKN1 | 0.45825643 |
| 106 | MST1R | 0.45403708 |
| 107 | HCK | 0.45358334 |
| 108 | BTK | 0.45177694 |
| 109 | PRKCZ | 0.44967359 |
| 110 | KIT | 0.44888656 |
| 111 | NEK6 | 0.44825985 |
| 112 | MAP3K3 | 0.44110580 |
| 113 | LATS2 | 0.42467664 |
| 114 | NTRK1 | 0.42425007 |
| 115 | NEK9 | 0.41543115 |
| 116 | RPS6KC1 | 0.41244395 |
| 117 | RPS6KL1 | 0.41244395 |
| 118 | EPHB1 | 0.40328220 |
| 119 | IRAK1 | 0.39701261 |
| 120 | JAK2 | 0.39304100 |
| 121 | NUAK1 | 0.37779748 |
| 122 | PIM1 | 0.36856823 |
| 123 | PASK | 0.35637557 |
| 124 | PDK1 | 0.35615521 |
| 125 | PRKD1 | 0.35073009 |
| 126 | FGFR4 | 0.34580550 |
| 127 | CAMK1D | 0.34127398 |
| 128 | MAPK12 | 0.33972426 |
| 129 | BMX | 0.33663247 |
| 130 | AKT3 | 0.33501104 |
| 131 | MAPK7 | 0.33430063 |
| 132 | SIK2 | 0.32534655 |
| 133 | PRKG2 | 0.32266316 |
| 134 | EPHA3 | 0.32176406 |
| 135 | STK10 | 0.32168088 |
| 136 | MAP3K7 | 0.32160365 |
| 137 | KSR2 | 0.31828877 |
| 138 | FGFR3 | 0.31639848 |
| 139 | DYRK3 | 0.31273898 |
| 140 | MARK2 | 0.31047472 |
| 141 | RPS6KA2 | 0.30777594 |
| 142 | RPS6KA6 | 0.30512174 |
| 143 | MAPK3 | 0.28538346 |
| 144 | TIE1 | 0.25494294 |
| 145 | IGF1R | 0.24286067 |
| 146 | INSR | 0.24092827 |
| 147 | PRKCD | 0.24020538 |
| 148 | PRKACB | 0.22322819 |
| 149 | ABL1 | 0.21854123 |
| 150 | RPS6KA1 | 0.20522671 |
| 151 | BRAF | 0.20380013 |
| 152 | TGFBR2 | 0.19988849 |
| 153 | PINK1 | 0.19034543 |
| 154 | CSNK1A1L | 0.18612175 |
| 155 | PRKAA1 | 0.17177279 |
| 156 | MAPK1 | 0.16932676 |
| 157 | WNK1 | 0.16351094 |
| 158 | FGFR2 | 0.16156702 |
| 159 | CDC42BPA | 0.15440701 |
| 160 | GSK3A | 0.15345493 |
| 161 | PRKD2 | 0.15298649 |
| 162 | EGFR | 0.14527420 |
| 163 | JAK1 | 0.14131422 |
| 164 | ILK | 0.13735881 |
| 165 | CSNK1A1 | 0.11173927 |
| 166 | ERBB2 | 0.11125668 |
| 167 | CSNK1G2 | 0.10475490 |
| 168 | CSNK1E | 0.09919477 |
| 169 | PRKCE | 0.09630438 |
| 170 | CAMK1G | 0.09584428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pancreatic secretion_Homo sapiens_hsa04972 | 8.27277688 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.84308370 |
| 3 | Protein digestion and absorption_Homo sapiens_hsa04974 | 5.66513858 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.83485058 |
| 5 | Protein export_Homo sapiens_hsa03060 | 3.60740589 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.40986153 |
| 7 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.95824644 |
| 8 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.88024873 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.71930447 |
| 10 | Asthma_Homo sapiens_hsa05310 | 2.67516891 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.66380316 |
| 12 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.54174469 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.39863094 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.39749031 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.33199223 |
| 16 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.31688960 |
| 17 | Pertussis_Homo sapiens_hsa05133 | 2.24446228 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09630606 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 2.06570469 |
| 20 | Malaria_Homo sapiens_hsa05144 | 2.04290769 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02581764 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00058305 |
| 23 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.96096180 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.95949735 |
| 25 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.92760883 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.92744749 |
| 27 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.77868927 |
| 28 | Salmonella infection_Homo sapiens_hsa05132 | 1.77226428 |
| 29 | Prion diseases_Homo sapiens_hsa05020 | 1.76312163 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75653421 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.74536875 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.73571534 |
| 33 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.68651614 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.65932282 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.65660161 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63218282 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.58435399 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.46646178 |
| 39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.42219793 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.37624147 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.23801408 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.18064902 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.17827072 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15520301 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.14091759 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.13485654 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.12643677 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12579951 |
| 49 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.08765776 |
| 50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.08278166 |
| 51 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.07304806 |
| 52 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07103414 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02262551 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00176088 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00150863 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.98195899 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.93535810 |
| 58 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.91147903 |
| 59 | Mineral absorption_Homo sapiens_hsa04978 | 0.90796790 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.89802825 |
| 61 | Insulin secretion_Homo sapiens_hsa04911 | 0.88277146 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87978142 |
| 63 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87931800 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 0.86568943 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 0.84186560 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84164430 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82209888 |
| 68 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.80479248 |
| 69 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.80191584 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77664168 |
| 71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77427905 |
| 72 | Hepatitis C_Homo sapiens_hsa05160 | 0.75868290 |
| 73 | Apoptosis_Homo sapiens_hsa04210 | 0.75800334 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74097188 |
| 75 | Influenza A_Homo sapiens_hsa05164 | 0.73585762 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.70041377 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69679638 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67468393 |
| 79 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66951995 |
| 80 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.66071750 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64764190 |
| 82 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.64480102 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63759561 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63448446 |
| 85 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.61548896 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.61381875 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.60592516 |
| 88 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.60558614 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60413921 |
| 90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59592113 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.58902119 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58054085 |
| 93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.55885735 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.55363944 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.54775073 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52157347 |
| 97 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50171307 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49706491 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.49568482 |
| 100 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.48073688 |
| 101 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48039032 |
| 102 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.47163180 |
| 103 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.46606710 |
| 104 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45235609 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.44265550 |
| 106 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43347203 |
| 107 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.42557505 |
| 108 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42282257 |
| 109 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.41981683 |
| 110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.41009948 |
| 111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.40953993 |
| 112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39497437 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38696389 |
| 114 | Lysosome_Homo sapiens_hsa04142 | 0.38477177 |
| 115 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36176321 |
| 116 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35170303 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.35140736 |
| 118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.34984731 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.34943895 |
| 120 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.32657989 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.32499749 |
| 122 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.31821176 |
| 123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30963831 |
| 124 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.28756678 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.28335533 |
| 126 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.28079750 |
| 127 | Prostate cancer_Homo sapiens_hsa05215 | 0.27158077 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27137210 |
| 129 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25992979 |
| 130 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.24235794 |
| 131 | HTLV-I infection_Homo sapiens_hsa05166 | 0.23948249 |
| 132 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23869394 |
| 133 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.22686319 |
| 134 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.21707635 |
| 135 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.21355470 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.20570902 |
| 137 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.19550591 |
| 138 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.18898050 |
| 139 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.18847617 |
| 140 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.17598121 |
| 141 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.17538727 |
| 142 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.17499977 |
| 143 | Sulfur relay system_Homo sapiens_hsa04122 | 0.17113757 |
| 144 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17069783 |
| 145 | Platelet activation_Homo sapiens_hsa04611 | 0.16199889 |
| 146 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.13743567 |
| 147 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.13638567 |
| 148 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.12683695 |
| 149 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.12221521 |
| 150 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.11719492 |
| 151 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.11569285 |
| 152 | Alzheimers disease_Homo sapiens_hsa05010 | 0.11390508 |
| 153 | Cocaine addiction_Homo sapiens_hsa05030 | 0.09936521 |
| 154 | Bladder cancer_Homo sapiens_hsa05219 | 0.09912395 |
| 155 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.09836024 |
| 156 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.09612224 |
| 157 | Carbon metabolism_Homo sapiens_hsa01200 | 0.09482608 |
| 158 | Bile secretion_Homo sapiens_hsa04976 | 0.09273406 |
| 159 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.08713500 |
| 160 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.08184828 |
| 161 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07793610 |
| 162 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.07397930 |
| 163 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.06588964 |
| 164 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.06152995 |
| 165 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.05980820 |
| 166 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.05404977 |
| 167 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.04197911 |
| 168 | Tight junction_Homo sapiens_hsa04530 | 0.03535692 |
| 169 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.03159025 |
| 170 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.02980020 |
| 171 | Histidine metabolism_Homo sapiens_hsa00340 | 0.02960241 |
| 172 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02671224 |
| 173 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.01429266 |
| 174 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.01399576 |

